Cytoplasmic CD24 expression has been identified as a marker of poor prognosis in gastric cancer [25], colorectal cancer [22, 23], ovarian cancer [20, 21] and malignant neoplasms of the salivary glands [26]. Here, CD24 is linked to ovarian carcinoma.